HUM: who owns it, and who’s predicted to buy next
Humana Inc · Health Care · on the Prior Moves forward board for 2026-09-30 at rank #10. Research, not investment advice.
Predicted to buy next quarter
3 tracked investors rank HUM in the top tenth of their own model’s candidates for 2026-09-30, strongest first. This is a forecast about a later filing, not a confirmation that anyone has bought the security or a recommendation to do so.
- Egerton
- Daniel Loeb · Third Point
- Stanley Druckenmiller · Duquesne
Strongest ranked investor signal: Egerton. No calibrated purchase probability is shown.
Currently disclosed holders
No investor in our tracked set discloses HUM in their latest 13F. The prediction above is a forward call, not a mirror of current holdings.
Mutual fund and ETF holders
416 US mutual funds and ETFs from 172 fund families reported a position in HUM for the quarter ending 2026-06-30. Against their own report a quarter earlier, 92 raised shares, 60 opened a new position, 194 cut and 41 sold out. Source: SEC Form N-PORT, which funds file about 60 days after quarter end. Share counts, not trades: a change can reflect fund inflows rather than a decision about HUM.
| Fund family | Funds | Share of fund-held shares |
|---|---|---|
| Vanguard Index Funds | 6 | 32.6% |
| Dodge & Cox Funds | 3 | 24.3% |
| Ishares Trust | 14 | 9.5% |
| American Funds Fundamental Investors | 1 | 6.5% |
| Select Sector Spdr Trust | 1 | 2.4% |
| Jpmorgan Trust Ii | 2 | 2.4% |
| Vanguard Institutional Index Funds | 2 | 2.0% |
| Mfs Series Trust Xi | 1 | 1.7% |
The predicted next buys, fresh disclosures, and the week’s catalysts. One email a week. Honest numbers, never advice.
See the full ranked board on top picks, how the PriorScore is built on how it works, the honest edge numbers on methodology, and the running accuracy on the prediction leaderboard. Forward quarter 2026-09-30, data as of 2026-10-17. Research, not investment advice, see the disclaimer.